Regular preventive treatment with the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) may help reduce the long-term risk of organ damage in people with congenital thrombotic…
News
Terbutaline, an asthma medication, reduced abnormal immune cell activity linked to platelet destruction in laboratory studies of mouse and patient cells with immune thrombocytopenia…
A man in his 80s with von Willebrand disease (VWD) type 1 underwent a heart procedure to treat atrial fibrillation, an irregular heartbeat that…
The risk of immune thrombocytopenia (ITP) in children may be elevated shortly after infection with influenza, according to a study based on insurance records…
Nearly all children and adolescents with immune-mediated thrombotic thrombocytopenic purpura (iTTP) achieved a clinical response with Cablivi (caplacizumab-yhdp), according to a medical records review.
A South Korean study found that people with immune thrombocytopenia (ITP) who received thrombopoietin receptor agonists (TPO-RAs) as second-line ITP treatment had a…
Persistent gum bleeding after a routine dental cleaning led to the diagnosis of a rare form of von Willebrand disease (VWD) in a woman.
The platelet variability index (PVI), a score that measures how low a patient’s platelet count is and how much their number of platelets changes over…
The final results of a now-completed global clinical trial have confirmed that the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) prevents acute disease episodes in people…
Nearly half of adults with immune thrombocytopenia (ITP) had cognitive impairment, particularly difficulties with memory, decision-making, and problem solving, a study found. However, the…
